N-[(3-Methylpyridin-2-yl)methyl]cyclopropanamine

Catalog No. :
ACYZAI259
CAS No. :
1249817-01-3
Molecular Formula :
C10H14N2
Molecular Weight :
162.24

IUPAC Name:N-((3-methylpyridin-2-yl)methyl)cyclopropanamine

N-[(3-Methylpyridin-2-yl)methyl]cyclopropanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$543.00Login to see priceInquiryInquiry
1g95%$1359.00Login to see priceInquiryInquiry
5g95%$2595.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[(3-Methylpyridin-2-yl)methyl]cyclopropanamine
IUPAC NameN-((3-methylpyridin-2-yl)methyl)cyclopropanamine
MDL No.MFCD16710390
Molecular FormulaC10H14N2
Molecular Weight162.24
SMILESCC1=C(CNC2CC2)N=CC=C1
InChI KeyVUBZGJKVRNGUIN-UHFFFAOYSA-N
SynonymCyclopropyl-(3-methylpyridin-2-ylmethyl)-amine;2-Pyridinemethanamine, N-cyclopropyl-3-methyl-;N-[(3-Methylpyridin-2-yl)methyl]cyclopropanamine
CAS No.1249817-01-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYZAI259 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQNUO508 route compound structure diagram
    ACQNUO50855589-47-4 In Stock
  2. Plus
  3. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  4. Then
  5. ACYZAI259 route product structure diagram
    ACYZAI2591249817-01-3
Inquiry

2. ACYZAI259 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBECA924 route compound structure diagram
    ACBECA9244377-43-9 In Stock
  2. Plus
  3. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  4. Then
  5. ACYZAI259 route product structure diagram
    ACYZAI2591249817-01-3
Inquiry

Comments (0)